Kinirons M T, Jackson S H, Kalra L, Trevit R T, Swift C G
Department of Health Care of the Elderly, King's College School of Medicine and Dentistry, King's College Hospital (Dulwich), East Dulwich Grove, London SE22 8PT.
Br J Clin Pharmacol. 1993 Oct;36(4):376-9. doi: 10.1111/j.1365-2125.1993.tb00381.x.
The psychomotor and cardiovascular effects of minaprine 100 mg, a novel antidepressant, were compared with amitriptyline 25 mg, as a positive control, and placebo in a single dose randomised double-blind crossover trial using an automated psychomotor test battery (APT), postural sway (PS), blood pressure (BP) and pulse in nine young and nine elderly healthy subjects. Analysis of variance, taking into account baseline values, showed that continuous attention test (CAT), critical flicker fusion threshold (CFFT), decision making test (DMT) and paired word association (PWA) were significantly impaired with amitriptyline compared with minaprine and placebo. Minaprine did not differ from placebo. Amitriptyline significantly lowered supine systolic blood pressure (BP) and all treatments produced significant decreases in heart rate in young and elderly. No age effect on psychomotor performance was seen. Minaprine compared favourably with amitriptyline using the APT with the doses used. The APT is useful in the evaluation of new drugs on psychomotor performance.
在一项单剂量随机双盲交叉试验中,使用自动精神运动测试电池(APT)、姿势摇摆(PS)、血压(BP)和脉搏,对9名年轻健康受试者和9名老年健康受试者比较了新型抗抑郁药米那普明100毫克与作为阳性对照的阿米替林25毫克及安慰剂的精神运动和心血管效应。考虑到基线值的方差分析表明,与米那普明和安慰剂相比,阿米替林显著损害了连续注意力测试(CAT)、临界闪烁融合阈值(CFFT)、决策测试(DMT)和配对词联想(PWA)。米那普明与安慰剂无差异。阿米替林显著降低仰卧位收缩压(BP),所有治疗均使年轻和老年受试者的心率显著降低。未观察到年龄对精神运动表现的影响。在所用剂量下,使用APT时,米那普明与阿米替林相比具有优势。APT可用于评估新药对精神运动表现的影响。